Martin Smith
Chief Tech/Sci/R&D Officer at IDEXX LABORATORIES, INC.
Net worth: 273 234 $ as of 2024-02-28
Profile
Currently, Martin Alexander Smith holds the position of Chief Technology Officer & Executive VP at IDEXX Laboratories, Inc.
Dr. Smith previously occupied the position of Chief Technology Officer at Pall Corp.
and Chief Technology Officer & Vice President at Cytiva.
Dr. Smith received a graduate degree from The University of Reading, an undergraduate degree from the University of Essex and a doctorate from University College London.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
IDEXX LABORATORIES, INC.
0.00% | 2024-02-13 | 475 ( 0.00% ) | 273 234 $ | 2024-02-28 |
Martin Smith active positions
Companies | Position | Start |
---|---|---|
IDEXX LABORATORIES, INC. | Chief Tech/Sci/R&D Officer | 2021-07-31 |
Former positions of Martin Smith
Companies | Position | End |
---|---|---|
Cytiva
Cytiva Pharmaceuticals: MajorHealth Technology Part of Danaher Corp., Cytiva is a life sciences leader that works with researchers, developers, and manufacturers to enable the delivery of transformative medicines. The private company is based in Marlborough, MA, with nearly 10,000 associates in more than 40 countries dedicated to customers ’ speed, flexibility, capacity, and efficiency in drug discovery, research, and manufacturing. Cytiva's mission is to advance and accelerate the development of therapeutics, providing critical support from discovery to delivery for customers spanning researchers, emerging biotech, large-scale biopharma, and contract manufacturers. Emmanuel Francois Joel Ligner has been the CEO of the company since 2020. Cytiva was acquired by Danaher Corp. from General Electric Co. on March 31, 2020 for $21,000 million. | Chief Tech/Sci/R&D Officer | 2021-06-30 |
PALL CORPORATION | Chief Tech/Sci/R&D Officer | 2020-07-31 |
Training of Martin Smith
The University of Reading | Graduate Degree |
University of Essex | Undergraduate Degree |
University College London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
IDEXX LABORATORIES, INC. | Health Technology |
Private companies | 2 |
---|---|
Pall Corp.
Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
Cytiva
Cytiva Pharmaceuticals: MajorHealth Technology Part of Danaher Corp., Cytiva is a life sciences leader that works with researchers, developers, and manufacturers to enable the delivery of transformative medicines. The private company is based in Marlborough, MA, with nearly 10,000 associates in more than 40 countries dedicated to customers ’ speed, flexibility, capacity, and efficiency in drug discovery, research, and manufacturing. Cytiva's mission is to advance and accelerate the development of therapeutics, providing critical support from discovery to delivery for customers spanning researchers, emerging biotech, large-scale biopharma, and contract manufacturers. Emmanuel Francois Joel Ligner has been the CEO of the company since 2020. Cytiva was acquired by Danaher Corp. from General Electric Co. on March 31, 2020 for $21,000 million. | Health Technology |